Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
355
-
Total 13F shares, excl. options
-
87M
-
Shares change
-
+3.33M
-
Total reported value, excl. options
-
$5.5B
-
Value change
-
+$227M
-
Put/Call ratio
-
0.91
-
Number of buys
-
199
-
Number of sells
-
-141
-
Price
-
$63.23
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2016
411 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2016.
RESMED INC - Common Stock (RMD) has 355 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87M shares
of 146M outstanding shares and own 59.37% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.7M shares), Capital World Investors (7.92M shares), FMR LLC (5.91M shares), BlackRock Fund Advisors (5.91M shares), STATE STREET CORP (4.47M shares), BlackRock Institutional Trust Company, N.A. (4.36M shares), Bank of New York Mellon Corp (2.45M shares), COMMONWEALTH BANK OF AUSTRALIA (2.03M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.81M shares), and PRUDENTIAL PLC (1.39M shares).
This table shows the top 355 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.